Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-07-27
2011-10-25
Desai, Rita (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S290000
Reexamination Certificate
active
08044204
ABSTRACT:
The invention provides compound and salts of Formula I and II, disclosed herein, which includes compounds of Formula A and Formula B:Such compounds possess useful antimicrobial activity. The variables R2, R3, R5, R6, R7, and R9shown in Formula A and B are defined herein.Certain compounds of Formula I and Formula II disclosed herein are potent and/or selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula I or Formula II and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula I or Formula II as the only active agent or may contain a combination of a compound of Formula I or Formula II and one or more other active agents. The invention also provides methods for treating microbial infections in animals.
REFERENCES:
patent: 4767762 (1988-08-01), Chu
patent: 5071848 (1991-12-01), Chu et al.
patent: 5087621 (1992-02-01), Pinol et al.
patent: 5387748 (1995-02-01), Demuth et al.
patent: 5519016 (1996-05-01), Kimura et al.
patent: 5580872 (1996-12-01), Chu et al.
patent: 5631256 (1997-05-01), Demuth, Jr. et al.
patent: 5646163 (1997-07-01), Demuth, Jr. et al.
patent: 5688791 (1997-11-01), Kimura et al.
patent: 6288081 (2001-09-01), Petersen et al.
patent: 2004/0029882 (2004-02-01), Ledoussal et al.
patent: 2005/0075363 (2005-04-01), Bradbury et al.
patent: 2006/0100215 (2006-05-01), Bradbury et al.
patent: 2006/0235041 (2006-10-01), Bradbury et al.
patent: 0394120 (1990-04-01), None
patent: 0227088 (1991-08-01), None
patent: 0878194 (1998-11-01), None
patent: 01160985 (1989-06-01), None
patent: 01193275 (1989-08-01), None
patent: 01265092 (1989-10-01), None
patent: 02174784 (1990-07-01), None
patent: 02243692 (1990-09-01), None
patent: 02255687 (1990-10-01), None
patent: 03058992 (1991-03-01), None
patent: 03209367 (1991-09-01), None
patent: 09288105 (1997-11-01), None
patent: 10130149 (1998-05-01), None
patent: 95/29894 (1995-11-01), None
patent: 02/48138 (2002-06-01), None
patent: 2005/019228 (2005-03-01), None
Wierenga, W., et al., “General, Efficient, One-Step Synthesis of Beta-Keto Esters,” J. Org. Chem., (1979) 44: 310-311.
Chu, D.T.W., et al., “Structure-Activity Relationships in Quinolone Antibacterials: Design, Sythesis and Biological Activities of Novel Isothiazoloquinolones,” Drugs Exptl. Clin. Research, (1988) 14(6): 379-83.
Shen, L.L., et al., “Mechanism of Inhibition of DNA Gyrase by Quinolone Antibacterials: A Cooperative Drug-DNA Binding Model,” Biochemistry, (1989) 28: 3886-3894.
Chu, D.T.W., et al. “Practical Synthesis of Iminochlorothioformates: Application of Iminochlorothioformates in the Synthesis of Novel 2,3,4,9-Tetrahydroisothiazolo[5,4-b][1,8]naphthyridine-3,4-diones and 2,3,4,9-Tetrahydroisothiazolo [5,4-b]quinoline-3,4-dione Derivatives,” J. Heterocyclic Chem., (1990) 27: 1191-1195.
Chu, D.T.W., “Syntheses of 6-Fluoru-7-piperazin-1-yl-9-cyclopropy1-2,3,4,9-tetrahydroisothiazolo[5,4-b]quinoline-3,4-dione and 6-Fluoro-7-piperazin-1-yl-9p-fluorophenyl-2,3,4,9-tetrahydroisothiazolo[5,4-b]quinoline-3,4-dione [1],” J. Heterocyclic Chem., (1990) 27: 839-843.
Kohlbrenner, W.E, et al., “Induction of Calf Thymus Topoisomerase II-Mediated DNA Breakage by the Antibacterial Isothiazoloquinolones A-65281 and A-65282,” Antimicrobial Agents and Chemotherapy, (1991) 36(1): 81-86.
Frigola, J., et al. “7-Azetidinylquinolones as Antibacterial Agents. Synthesis and Structure-Activity Relationships,” J. Med. Chem, (1993) 36(7): 801-810.
Chung, S.K. et al., “Geometry Mapping of N(1)-Substituents of Quinolone Antibacterials and the Antibacterial Mode of Actions,” Korean J. of Med. Chem., (1993) 3(2): 148-161.
Nahm, K. et al., “Quinolone Compounds with Carboxylic Equivalents and Semiempirical Calculations on their Tautomers,” Biorganic & Medicinal Chemistry Letters, (1993) 3(12): 2631-2634.
Frigola, J., et al., “7-Azetidinylquinolones as Antibacterial Agents. 2. 1 synthesis and Biological Activity of 7-92,3-Disubstituted-1-azetidinyl)-4-oxoquinoline- and 1,8-naphthyridine-3-carboxylic Acids. Properties and Structure—Activity Relationships of Quinolones with an Azetidine Moiety,” J. Med. Chem., (1994) 37(24): 4195-4210.
Lenoir, E.A., et al., “An Efficient Method for the Synthesis of (R)-3-(1-Amino-1-methylethyl)pyrrolidines for the Antiinfective Agent, PD 138312,” Tetrahedron: Asymmetry, (1994), 5: 1131-1134.
Reuman, M., et al., “Synthesis and Antibacterial Activity of Some Novel 1-Substituted 1,4-Dihydro-4-oxo-7-pyridiny1-3-quinolinecarboxylic Acids. Potent Antistaphylococcal Agents,” J. Med. Chem. (1995) 38: 2531-2540.
Tamao K., and Miyaura, N., “Introduction to Cross-Coupling Reactions,” Topics in Current Chemistry (2002) 219: 1-9.
Inagaki, H., et al., “Synthesis and Structure-Activity Relationships of 5-Amino-6-fluoro-1-[(1R,2S)-2fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic Acid Antibacterials Having Fluorinated 7-[(3R)-3-(1-Aminocyclopropan-1-y1) pyrrolidin-1-yl] Substituents”, J. Med. Chem., (2003) 46: 1005-1015.
Potemkin, V.A. et al., “Theoretical Investigation of the Antituberculous Activity of Membranotropic Podands,” Pharmaceutical Chemistry Journal (translation of Khimiko-Farmatsevticheskii Zhurnal), (2003) 37: 468-472.
Bradbury Barton James
Deshpande Milind
Hashimoto Akhiro
Kim Ha Young
Lucien Edlaine
Achillion Pharmaceuticals, Inc.
Cantor & Colburn LLP
Desai Rita
LandOfFree
8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4271199